Enhua Pharmaceutical Co., Ltd. "penehyclidine hydrochloride injection" obtained the approval for drug registration
-
Last Update: 2020-01-15
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Enhua Pharmaceutical Co., Ltd announced that it has recently obtained the approval document for drug registration of three specifications of the chemical "penehyclidine hydrochloride injection" approved and issued by the State Food and drug administration According to the announcement, penehyclidine hydrochloride injection is a selective anticholinergic drug, which can be used for administration before anesthesia to inhibit the secretion of salivary glands and airway glands, as well as emergency treatment of organophosphorus toxicosis (pesticides) and maintenance of atropinization after poisoning or aging of cholinesterase (CHE) The product has been listed in the national medical insurance catalogue (2019 version) class B medicine and the national essential medicine catalogue (2018 version) Details of three specifications of penehyclidine hydrochloride injection drug registration approval: Mengmeng
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
